They identified a stroma-induced signature in tumor cells, including AKT, Ras, NF-kB, HIF-1α, Myc, hTert and IRF4 signaling pathways, which is correlated with an adverse clinical prognosis. The gene discussed is NFKB1; the disease is neoplasm.